Lotus Health Group Co (600186) - Net Assets
Based on the latest financial reports, Lotus Health Group Co (600186) has net assets worth CN¥2.09 Billion CNY (≈ $306.44 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥3.86 Billion ≈ $565.38 Million USD) and total liabilities (CN¥1.77 Billion ≈ $258.94 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Lotus Health Group Co strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥2.09 Billion |
| % of Total Assets | 54.2% |
| Annual Growth Rate | 6.84% |
| 5-Year Change | 54.18% |
| 10-Year Change | 5948.05% |
| Growth Volatility | 167.4 |
Lotus Health Group Co - Net Assets Trend (1995–2025)
This chart illustrates how Lotus Health Group Co's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see 600186 market cap.
Annual Net Assets for Lotus Health Group Co (1995–2025)
The table below shows the annual net assets of Lotus Health Group Co from 1995 to 2025. Also explore 600186 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.80 Billion ≈ $263.99 Million |
+19.02% |
| 2024-12-31 | CN¥1.52 Billion ≈ $221.80 Million |
+14.11% |
| 2023-12-31 | CN¥1.33 Billion ≈ $194.37 Million |
+12.80% |
| 2022-12-31 | CN¥1.18 Billion ≈ $172.31 Million |
+0.64% |
| 2021-12-31 | CN¥1.17 Billion ≈ $171.22 Million |
+675.10% |
| 2020-12-31 | CN¥150.96 Million ≈ $22.09 Million |
+105.20% |
| 2019-12-31 | CN¥73.57 Million ≈ $10.77 Million |
+114.86% |
| 2018-12-31 | CN¥-494.92 Million ≈ $-72.42 Million |
-346.76% |
| 2017-12-31 | CN¥-110.78 Million ≈ $-16.21 Million |
-471.39% |
| 2016-12-31 | CN¥29.83 Million ≈ $4.36 Million |
+148.55% |
| 2015-12-31 | CN¥12.00 Million ≈ $1.76 Million |
-97.85% |
| 2014-12-31 | CN¥558.65 Million ≈ $81.75 Million |
+0.85% |
| 2013-12-31 | CN¥553.92 Million ≈ $81.06 Million |
-37.91% |
| 2012-12-31 | CN¥892.18 Million ≈ $130.55 Million |
+4.44% |
| 2011-12-31 | CN¥854.27 Million ≈ $125.01 Million |
-35.11% |
| 2010-12-31 | CN¥1.32 Billion ≈ $192.63 Million |
+1.71% |
| 2009-12-31 | CN¥1.29 Billion ≈ $189.39 Million |
+16.85% |
| 2008-12-31 | CN¥1.11 Billion ≈ $162.08 Million |
-21.46% |
| 2007-12-31 | CN¥1.41 Billion ≈ $206.38 Million |
-9.57% |
| 2006-12-31 | CN¥1.56 Billion ≈ $228.22 Million |
-20.54% |
| 2005-12-31 | CN¥1.96 Billion ≈ $287.22 Million |
+0.24% |
| 2004-12-31 | CN¥1.96 Billion ≈ $286.54 Million |
-0.09% |
| 2003-12-31 | CN¥1.96 Billion ≈ $286.79 Million |
-6.76% |
| 2002-12-31 | CN¥2.10 Billion ≈ $307.59 Million |
+1.79% |
| 2001-12-31 | CN¥2.07 Billion ≈ $302.18 Million |
+42.69% |
| 2000-12-31 | CN¥1.45 Billion ≈ $211.77 Million |
+13.47% |
| 1999-12-31 | CN¥1.28 Billion ≈ $186.63 Million |
+11.92% |
| 1998-12-31 | CN¥1.14 Billion ≈ $166.75 Million |
+269.07% |
| 1997-12-31 | CN¥308.76 Million ≈ $45.18 Million |
+15.34% |
| 1996-12-31 | CN¥267.70 Million ≈ $39.17 Million |
+8.01% |
| 1995-12-31 | CN¥247.85 Million ≈ $36.27 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Lotus Health Group Co's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 86714750232.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CN¥2.83 Billion | 144.19% |
| Total Equity | CN¥1.96 Billion | 100.00% |
Lotus Health Group Co Competitors by Market Cap
The table below lists competitors of Lotus Health Group Co ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Guosheng Financial Holding Inc
SHE:002670
|
$3.31 Billion |
|
TELEPERFORMANCE SE ADR
F:RCF0
|
$3.31 Billion |
|
CIA EN.GER. ADR 1
F:CIDS
|
$3.31 Billion |
|
Shyam Metalics and Energy Limited
NSE:SHYAMMETL
|
$3.31 Billion |
|
Simmons First National Corporation
NASDAQ:SFNC
|
$3.31 Billion |
|
International Game Technology PLC
NYSE:IGT
|
$3.31 Billion |
|
Emerald Resources NL
AU:EMR
|
$3.30 Billion |
|
AllianceBernstein Holding L.P.
NYSE:AB
|
$3.30 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Lotus Health Group Co's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,697,120,428 to 1,962,208,445, a change of 265,088,017 (15.6%).
- Net income of 309,119,429 contributed positively to equity growth.
- Dividend payments of 32,170,626 reduced retained earnings.
- Other comprehensive income decreased equity by 102,707,065.
- Other factors increased equity by 90,846,279.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥309.12 Million | +15.75% |
| Dividends Paid | CN¥32.17 Million | -1.64% |
| Other Comprehensive Income | CN¥-102.71 Million | -5.23% |
| Other Changes | CN¥90.85 Million | +4.63% |
| Total Change | CN¥- | 15.62% |
Book Value vs Market Value Analysis
This analysis compares Lotus Health Group Co's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 11.52x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 54.19x to 11.52x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1995-12-31 | CN¥0.23 | CN¥12.61 | x |
| 1996-12-31 | CN¥0.25 | CN¥12.61 | x |
| 1997-12-31 | CN¥0.29 | CN¥12.61 | x |
| 1998-12-31 | CN¥1.07 | CN¥12.61 | x |
| 1999-12-31 | CN¥1.20 | CN¥12.61 | x |
| 2000-12-31 | CN¥1.36 | CN¥12.61 | x |
| 2001-12-31 | CN¥1.94 | CN¥12.61 | x |
| 2002-12-31 | CN¥1.96 | CN¥12.61 | x |
| 2003-12-31 | CN¥1.82 | CN¥12.61 | x |
| 2004-12-31 | CN¥1.82 | CN¥12.61 | x |
| 2005-12-31 | CN¥1.83 | CN¥12.61 | x |
| 2006-12-31 | CN¥1.46 | CN¥12.61 | x |
| 2007-12-31 | CN¥1.33 | CN¥12.61 | x |
| 2008-12-31 | CN¥1.07 | CN¥12.61 | x |
| 2009-12-31 | CN¥1.22 | CN¥12.61 | x |
| 2010-12-31 | CN¥1.25 | CN¥12.61 | x |
| 2011-12-31 | CN¥0.81 | CN¥12.61 | x |
| 2012-12-31 | CN¥0.66 | CN¥12.61 | x |
| 2013-12-31 | CN¥0.42 | CN¥12.61 | x |
| 2014-12-31 | CN¥0.39 | CN¥12.61 | x |
| 2015-12-31 | CN¥0.07 | CN¥12.61 | x |
| 2016-12-31 | CN¥0.10 | CN¥12.61 | x |
| 2017-12-31 | CN¥0.03 | CN¥12.61 | x |
| 2018-12-31 | CN¥-0.22 | CN¥12.61 | x |
| 2019-12-31 | CN¥0.22 | CN¥12.61 | x |
| 2020-12-31 | CN¥0.26 | CN¥12.61 | x |
| 2021-12-31 | CN¥0.95 | CN¥12.61 | x |
| 2022-12-31 | CN¥0.92 | CN¥12.61 | x |
| 2023-12-31 | CN¥0.83 | CN¥12.61 | x |
| 2024-12-31 | CN¥1.01 | CN¥12.61 | x |
| 2025-12-31 | CN¥1.09 | CN¥12.61 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Lotus Health Group Co utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 15.75%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.95%
- • Asset Turnover: 0.95x
- • Equity Multiplier: 1.85x
- Recent ROE (15.75%) is above the historical average (-22.64%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1995 | 20.81% | 3.99% | 1.78x | 2.93x | CN¥26.80 Million |
| 1996 | 20.59% | 3.73% | 1.68x | 3.29x | CN¥28.34 Million |
| 1997 | 32.60% | 6.54% | 1.51x | 3.30x | CN¥69.78 Million |
| 1998 | 8.81% | 8.22% | 0.69x | 1.55x | CN¥-13.54 Million |
| 1999 | 13.22% | 13.56% | 0.49x | 1.98x | CN¥41.03 Million |
| 2000 | 11.87% | 13.11% | 0.42x | 2.14x | CN¥27.10 Million |
| 2001 | 7.04% | 10.48% | 0.32x | 2.09x | CN¥-61.10 Million |
| 2002 | 0.93% | 1.58% | 0.26x | 2.21x | CN¥-189.11 Million |
| 2003 | -7.50% | -12.39% | 0.25x | 2.40x | CN¥-339.27 Million |
| 2004 | 0.24% | 0.48% | 0.21x | 2.32x | CN¥-189.12 Million |
| 2005 | 0.50% | 0.73% | 0.31x | 2.20x | CN¥-184.75 Million |
| 2006 | 0.67% | 0.56% | 0.49x | 2.46x | CN¥-145.52 Million |
| 2007 | 0.88% | 0.56% | 0.58x | 2.69x | CN¥-128.68 Million |
| 2008 | 1.13% | 0.61% | 0.59x | 3.14x | CN¥-98.29 Million |
| 2009 | 14.73% | 7.69% | 0.69x | 2.76x | CN¥61.27 Million |
| 2010 | 1.33% | 0.65% | 0.82x | 2.48x | CN¥-114.32 Million |
| 2011 | -53.37% | -16.62% | 0.94x | 3.43x | CN¥-545.02 Million |
| 2012 | 4.03% | 1.44% | 0.90x | 3.10x | CN¥-54.09 Million |
| 2013 | -56.39% | -15.26% | 0.83x | 4.46x | CN¥-387.57 Million |
| 2014 | 3.98% | 1.19% | 0.76x | 4.39x | CN¥-36.11 Million |
| 2015 | -556.61% | -28.63% | 0.79x | 24.58x | CN¥-517.62 Million |
| 2016 | 47.43% | 3.69% | 0.85x | 15.09x | CN¥51.49 Million |
| 2017 | -302.95% | -5.58% | 0.98x | 55.33x | CN¥-106.85 Million |
| 2018 | 0.00% | -19.23% | 1.01x | 0.00x | CN¥-302.69 Million |
| 2019 | 22.27% | 4.07% | 0.79x | 6.92x | CN¥38.14 Million |
| 2020 | 19.28% | 4.49% | 1.10x | 3.90x | CN¥35.76 Million |
| 2021 | 3.16% | 2.44% | 0.80x | 1.61x | CN¥-96.22 Million |
| 2022 | 3.27% | 2.73% | 0.70x | 1.72x | CN¥-95.05 Million |
| 2023 | 8.45% | 6.18% | 0.86x | 1.58x | CN¥-23.92 Million |
| 2024 | 11.94% | 7.65% | 0.73x | 2.14x | CN¥32.87 Million |
| 2025 | 15.75% | 8.95% | 0.95x | 1.85x | CN¥112.90 Million |
Industry Comparison
This section compares Lotus Health Group Co's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $1,489,328,454
- Average return on equity (ROE) among peers: 14.99%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Lotus Health Group Co (600186) | CN¥2.09 Billion | 20.81% | 0.84x | $3.31 Billion |
| Shenzhen Shenbao Industrial Co Ltd (000019) | $1.05 Billion | 9.20% | 0.12x | $1.15 Billion |
| Hainan Pearl River Holdings Co Ltd (000505) | $2.84 Billion | 5.92% | 0.73x | $649.98 Million |
| Xiwang Foodstuffs Co Ltd (000639) | $99.21 Million | 12.46% | 0.45x | $255.89 Million |
| Nanfang Black Sesame Group Co Ltd (000716) | $277.26 Million | 58.42% | 2.01x | $558.56 Million |
| CNFC Overseas Fishery Co Ltd (000798) | $1.64 Billion | -7.20% | 2.63x | $543.40 Million |
| Henan Shuanghui Investment & Development Co Ltd (000895) | $3.03 Billion | 23.09% | 0.47x | $11.81 Billion |
| Xinjiang Chalkis Co Ltd (000972) | $217.63 Million | 29.42% | 16.12x | $440.17 Million |
| Zhengzhou Qianweiyangchu Food Co Ltd (001215) | $1.82 Billion | 4.59% | 0.27x | $432.93 Million |
| Qingdao Foods Co Ltd (001219) | $923.11 Million | 9.90% | 0.10x | $355.80 Million |
| Shandong Oriental Ocean Sci-Tech Co Ltd (002086) | $3.00 Billion | 4.14% | 0.35x | $576.18 Million |
About Lotus Health Group Co
Lotus Holdings Co.,Ltd. engages in the production and sale of condiments and health food in China and internationally. The company offers soy sauce, oyster sauce, vinegar, cooking wine, braised sauce, and sesame oil; chicken essence, chicken powder, chicken juice, seasoning, dumpling materials, fried vegetables, spicy fresh and fresh mushroom, as well as octagonal, white pepper, black pepper, and… Read more